Ibex Ltd Director Keen Shuja Sells Shares Worth Over $27,000 Via Investing.com

Keen Shuja, Director at IBEX Ltd (NASDAQ: ), recently sold a total of 1,345 shares of the company at a weighted average price between $20.45 and $20.47. The total value of the shares sold amounted to approximately $27,507. This transaction was executed on September 23, 2024 and is part of the latest filings with the US Securities and Exchange Commission.

The shares sold by Shuja represent part of his holdings in IBEX Ltd, with the director still holding 138,679 shares after the deal. The sale was made through multiple transactions and the price reported reflects the weighted average sale price. Keen Shuja has expressed a willingness to provide complete information regarding the number of shares sold at each price separately upon request to either the issuer, any securityholder of the issuer, or the SEC staff.

IBEX Ltd, a specialist computer processing and data preparation services company, is established and headquartered in Washington DC. This recent sale by a member of the company’s board of directors may be of interest to current and potential investors who closely monitor insider trading activities for information. in company performance and executive confidence.

The sale was approved by Lisa Lenstrohm, as attorney-in-fact, on 24 September 2024. To date, there have been no further observations or comments provided by Shuja or IBEX Ltd regarding the rationale behind the sale or any potential impact on operations or company strategy.

In other recent news, IBEX Ltd. reported a transformative year with record earnings per share (EPS) growth to $2.10 and free cash flow growth to $27 million. Despite a slight year-over-year decline in revenue to $509 million, IBEX’s Q4 revenue showed a year-over-year increase, suggesting a return to growth. The company enters fiscal 2025 with a positive outlook, expecting revenue of $510 million to $525 million and adjusted EBITDA of $67 million to $69 million.

Financial services firm Baird upped their target price on shares of IBEX to $23.00, up from their previous target of $20.00, maintaining an Outperform rating. RBC Capital Markets raised its price target on IBEX from $18 to $20, maintaining a Sector Perform rating. Both adjustments are based on recent developments and the company’s financial projections.

Baird highlighted the company’s aspirations to achieve 5-7% revenue growth and 15% EBITDA margins over time, with AI playing a significant role in driving these margin expansion opportunities. The firm also noted that fourth-quarter IBEX revenue, EBITDA and EPS beat Wall Street expectations. RBC Capital Markets echoed similar sentiments, reflecting confidence in IBEX’s strategic direction, which includes a focus on more profitable service areas and the implementation of advanced technologies.

InvestingPro Insights

Amid recent insider trading activity at IBEX Ltd, the market has shown a strong performance for the company’s shares. According to InvestingPro data, IBEX Ltd has seen a notable increase in its share price over different timeframes, including a 33.93% increase over the past six months and a 34.38% return over the past year. This suggests that investor confidence in the company may remain high despite the executive selling shares.

InvestingPro Tips indicates that IBEX Ltd is currently trading at a low P/E ratio relative to near-term earnings growth, with a P/E ratio of 10.5 and an adjusted trailing-twelve-month P/E ratio of Q4 2024 at 9.3. Furthermore, the company’s return on assets for the same period is 11.46%, reflecting the efficient use of its assets to generate profits. These indicators, along with the stock’s strong performance, could be seen as signs of underlying strength in the company’s financial and market position.

Furthermore, the company has been identified as having a high return to shareholders, which is often a signal of management’s commitment to returning value to shareholders. Another InvestingPro tip points out that management has been aggressively buying shares, which can be a positive indicator of the company’s belief in its own undervalued stock and a potential catalyst for future price appreciation.

For investors interested in a deeper analysis, there are additional InvestingPro Tips available for IBEX Ltd which can be accessed through the InvestingPro platform. These tips provide additional information that may help investors make more informed decisions about their investment in IBEX Ltd.

This article was generated with support from AI and reviewed by an editor. For more information, see T&C.